Uremia does not affect neointima formation in mice
Abstract Atherosclerotic cardiovascular disease is a major complication of chronic kidney disease (CKD). CKD leads to uremia, which modulates the phenotype of aortic smooth muscle cells (SMCs). Phenotypic modulation of SMCs plays a key role in accelerating atherosclerosis. We investigated the hypoth...
Guardado en:
Autores principales: | Annemarie Aarup, Carsten H. Nielsen, Line S. Bisgaard, Ilze Bot, Henrik H. El-Ali, Andreas Kjaer, Lars B. Nielsen, Tanja X. Pedersen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c01d0b83ed9c46878998b6f64f53187a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Volatile organic compounds in uremia.
por: Nikolaos Pagonas, et al.
Publicado: (2012) -
NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ
por: Peipei Luan, et al.
Publicado: (2019) -
Deletion of DGCR8 in VSMCs of adult mice results in loss of vascular reactivity, reduced blood pressure and neointima formation
por: Yanan Zou, et al.
Publicado: (2018) -
<italic toggle="yes">Candida</italic> Administration Worsens Uremia-Induced Gut Leakage in Bilateral Nephrectomy Mice, an Impact of Gut Fungi and Organismal Molecules in Uremia
por: Wimonrat Panpetch, et al.
Publicado: (2021) -
TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.
por: Jacco C Karper, et al.
Publicado: (2013)